SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-091996
Filing Date
2024-04-10
Accepted
2024-04-10 16:50:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d773582dsc13da.htm SC 13D/A 31618
  Complete submission text file 0001193125-24-091996.txt   33093
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Subject) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92247 | Film No.: 24836403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
Xontogeny, LLC (Filed by) CIK: 0001844296 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A